Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
Employees - 2,
CEO - Mr. Tomer Izraeli,
Sector - Healthcare,
Country - IL,
Market Cap - 1.82M
Altman ZScore(max is 10): -1.74, Piotroski Score(max is 10): 2, Working Capital: $2392000, Total Assets: $5547000, Retained Earnings: $-5066000, EBIT: -1803000, Total Liabilities: $261000, Revenue: $0
- Current Price $0.01 - Analyst Target Price $-| Ticker | PLRZ |
| Index | - |
| Curent Price | 0.01 |
| Change | -21.21% |
| Market Cap | 1.82M |
| Average Volume | 44.15M |
| Income | -1.55M |
| Sales | 0.00M |
| Book Value/Share | 1.26 |
| Cash/Share | 0.01 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 6 |
| Moving Avg 20days | -98.55% |
| Moving Avg 50days | -98.78% |
| Moving Avg 200days | -99.45% |
| Shares Outstanding | 6.81M |
| Earnings Date | - |
| Inst. Ownership | 5.25% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | - |
| Price/Book | 0.00 |
| Price/Cash | 0.71 |
| Price/FCF | - |
| Quick Ratio | 10.16 |
| Current Ratio | 10.16 |
| Debt/Equity | 0.00 |
| Return on Assets | -50.61% |
| Return on Equity | -57.83% |
| Return on Investment | -29.23% |
| Gross Margin | - |
| Ops Margin | - |
| Profit Margin | - |
| RSI | 35.16 |
| BETA(β) | - |
| From 52week Low | - |
| From 52week High | -99.89% |
| EPS | -0.37 |
| EPS next Year | - |
| EPS next Qtr | - |
| EPS this Year | - |
| EPS next 5 Year | - |
| EPS past 5 Year | - |
| Sales past 5 Year | 0.00% |
| EPS Y/Y | -157.55% |
| Sales Y/Y | - |
| EPS Q/Q | -134.05% |
| Sales Q/Q | - |
| Sales Surprise | - |
| EPS Surprise | - |
| ATR(14) | 0.13 |
| Perf Week | -81.75% |
| Perf Month | -98.42% |
| Perf Quarter | -99.52% |
| Perf Year | - |
| Perf YTD | -99.76% |
| Target Price | - |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer